EcoDrugPlus

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSUPAG00010015704
Gene Symbol: IDH2
1 Cross references
261 Possible Orthologues:

Kallikrein B1

Ensembl ID : ENSUPAG00010006524
Gene Symbol: KLKB1
1 Cross references
206 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSUPAG00010001991
Gene Symbol: KEAP1
1 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSUPAG00010020785
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSUPAG00010011823
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSUPAG00010007752
Gene Symbol: KIF5B
3 Cross references
280 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSUPAG00010006436
Gene Symbol: LTA4H
3 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSUPAG00010009278
Gene Symbol: LTB4R2
3 Cross references
236 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSUPAG00010020880
Gene Symbol: KDM1A
3 Cross references
213 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSUPAG00010017498
Gene Symbol: LOXL2
1 Cross references
287 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSUPAG00010022660
Gene Symbol: MST1R
1 Cross references
266 Possible Orthologues:

Maltase-Glucoamylase

Ensembl ID : ENSUPAG00010016104
Gene Symbol: MGAM
3 Cross references
312 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).